Altre lingue Supriya Lifescience Limited

Azioni

SUPRIYA

INE07RO01027

Prezzo di chiusura NSE India S.E. Altri mercati azionari 00:00:00 11/06/2024			Variaz. 5gg	Var. 1 gen.
374,9 ^INR	+2,15%		+4,36%	+19,11%

28/05	Supriya Lifescience Limited approva i cambiamenti dei dirigenti	CI
28/05	Supriya Lifescience Limited riporta i risultati degli utili per il quarto trimestre conclusosi il 31 marzo 2024	CI

Altre lingue

Sblocca tutte le notizie su tutte le aziende: non perdere mai più un'opportunità di investimento redditizia!

Registrazione 100% gratuita

Supriya Lifescience Limited Approves Executive Changes	28/05
Supriya Lifescience Limited Recommends Final Dividend for the Fiscal 2024	28/05
Supriya Lifescience Limited Reports Earnings Results for the Fourth Quarter Ended March 31, 2024	28/05
Supriya Lifescience Limited Reports Earnings Results for the Full Year Ended March 31, 2024	28/05
Supriya Lifescience Limited Reports Earnings Results for the Third Quarter and Nine Months Ended December 31, 2023	07/02
Supriya Lifescience Limited Announces Approval of Capital Expenditure at Ambernath Site for CDMO Facility	07/02
Supriya Lifescience Limited Reports Earnings Results for the Third Quarter and Nine Months Ended December 31, 2023	07/02
Supriya Lifescience Gets Brazil's Health Authority's GMP Certification for Site in India	05/01
Supriya Lifescience Ltd Signs Agreement with Kalinga Institute of Technology for Further Development of Wound Healing Gel	06/11
Supriya Lifescience Ties Up with Kalinga Institute for Oral Cancer Detection Kit	24/10/23
Supriya Lifescience Ltd Collaborates with Kalinga Institute of Industrial Technology to Develop One of its Kind Oral Cancer Detection Kit Named Quickblue Oral Kit	23/10/23
Supriya Lifescience Limited Reports Earnings Results for the First Quarter Ended June 30, 2023	03/08/23
Supriya Lifescience Limited Reports Earnings Results for the First Quarter Ended June 30, 2023	03/08/23
Supriya Lifescience Ltd. and Plasma Nutrition, Inc Announce Collaboration in Protein Technology	02/08/23
Supriya Lifescience Limited Executes A Long-Term Supply and Sales Agreement with A Leading Company in Europe for the Supply of Active Pharmaceutical Ingredient	29/05/23
Supriya Lifescience Limited Recommends Final Dividend for the Year Ended March 31, 2023	26/05/23
Supriya Lifescience Names President for Business Development, Strategy and R&D	26/05/23
Supriya Lifescience Limited Reports Earnings Results for the Full Year Ended March 31, 2023	26/05/23
Supriya Lifescience Limited Reports Earnings Results for the Fourth Quarter Ended March 31, 2023	26/05/23
Supriya Lifescience Limited Announces Resignation of Manoj Dorlikar as Whole Time Director	26/05/23

Non ci sono risultati per questa ricerca

Tutte le notizie Raccomandazione analisti Eventi più importanti Insiders Resoconti Comunicati stampa Pubblicazioni ufficiali Altre lingue Idee di trading Articoli MarketScreener Analisi MarketScreener

Altre lingue Supriya Lifescience Limited

Azioni

SUPRIYA

INE07RO01027

Altre lingue

Filtri